Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00445367 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Biobank For MS And Other Demyelinating Diseases

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Oct 2026 to Oct 2030v20
  2. Study Status, Referencesv19
  3. Completion date: Oct 2036v18
  4. 2 versions Re-verified since Jan 13, 2018, no change to tracked fieldsv16-v17
  5. Enrollment target: 3226 Primary completion date: Oct 2026v15 Show 1 more changeShow less
    • Primary completion date: Oct 2026
Show 13 earlier versionsHide 13 earlier versions
  1. Trial status: Enrolling by Invitation to Active, Not Recruitingv14
  2. Trial status: Recruiting to Enrolling by Invitation Site details revised at 10 of 10 sitesv13 Show 1 more changeShow less
    • Site details revised at 10 of 10 sites
  3. Site contacts updated at 10 of 10 sitesv12
  4. Study sites: 9 to 10v11
  5. Study sites: 8 to 9v10
  6. Study sites: 6 to 8v9
  7. Re-verified, no change to tracked fieldsv8
  8. Eligibility criteria expanded, about 27 wordsv7 See this version in full on ClinicalTrials.gov ↗
  9. Site contacts updated at 6 of 6 sitesv6
  10. Site contacts updated at 1 of 6 sitesv5
  11. Site details revised at 1 of 6 sitesv4
  12. Site contacts updated at 1 of 6 sitesv3
  13. Site contacts updated at 2 of 6 sitesv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Devic's, Acute Disseminated Encephalomyelitis (ADEM), and Optic Neuritis (ON)), and related and unrelated unaffected controls. Samples and data will be available as a shared resource to scientists researching the causes, sub-types, and biomarkers of MS and related demyelinating diseases.
Trial Details
NCT Number NCT00445367
Lead Sponsor Accelerated Cure Project for Multiple Sclerosis
Conditions Multiple Sclerosis, Transverse Myelitis, Neuromyelitis Optica, Acute Disseminated Encephalomyelitis, Optic Neuritis
Enrollment 3,226 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov